Christos Venetis

ORCID: 0000-0001-9591-7222 · 16 papers in corpus
observational 2026
JAMA network open ·doi:10.1001/jamanetworkopen.2026.1332

IMPORTANCE: High-quality evidence on cancer occurrence for women who have used medically assisted reproduction (MAR) is required to guide care. OBJECTIVE: To compare cancer incidence in MAR-exposed women with the general population of wome…

observational 2026
JAMA network open ·doi:10.1001/jamanetworkopen.2026.22832

IMPORTANCE: It is critical that women undertaking medically assisted reproductive (MAR) treatment and their clinicians know whether the treatments are associated with an increased risk of hormone-related cancers. OBJECTIVE: To determine th…

review 2026
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1845946

Delayed parenthood is a defining feature of contemporary reproductive medicine, fundamentally reshaping reproductive planning and increasing reliance on medically assisted reproduction (MAR). For women of advanced reproductive age (ARA), th…

other 2026
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.12.010
observational 2025
International journal of molecular sciences ·doi:10.3390/ijms26041656

Studies in animals have shown that androgens promote early follicular development and granulosa cell proliferation by augmenting follicle-stimulating hormone (FSH) receptor expression in granulosa cells. Inconsistency exists regarding the a…

meta-analysis 2025
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deae274

STUDY QUESTION: Is the probability of pregnancy different between women using biosimilars versus the originator of follitropin alfa for ovarian stimulation in ART? SUMMARY ANSWER: Meta-analysis of eight randomized clinical trials (RCTs) su…

observational 2025
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaf121

STUDY QUESTION: What is the incidence of and risk factors for monozygotic twinning (MZT) following single embryo transfer (SET) in ART cycles in Australia and New Zealand? SUMMARY ANSWER: MZT occurred in 1.5% of live births following SET, …

observational 2025
Fertility and sterility ·doi:10.1016/j.fertnstert.2024.12.007

OBJECTIVE: To evaluate whether perinatal and infant outcomes differ between singleton births after assisted reproductive technology (ART) in women with endometriosis alone and those with other causes of infertility. DESIGN: Population-base…

guideline 2025
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.05.168

OBJECTIVE: To provide a framework for conducting rigorous nonrandomized studies of interventions in fertility treatment research, addressing their role as complements to randomized controlled trials (RCTs) in evaluating treatment outcomes. …

other 2024
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deae053

Researchers interested in causal questions must deal with two sources of error: random error (random deviation from the true mean value of a distribution), and bias (systematic deviance from the true mean value due to extraneous factors). F…

observational 2023
Reproduction & fertility ·doi:10.1530/raf-22-0128

A prospective longitudinal cohort study aimed to longitudinally examine the kinetics of Anti-müllerian hormone (AMH) during the first two trimesters of pregnancy. Pregnant women with stored 1st trimester serum samples were recruited at 24-2…

meta-analysis 2023
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-023-01141-2

RESEARCH QUESTION: To evaluate the role of endometrial scratching performed prior to an embryo transfer cycle on the probability of pregnancy compared to placebo/sham or no intervention. DESIGN: A computerized literature (using a specific …

meta-analysis 2023
Human Reproduction Update ·doi:10.1093/humupd/dmac040

BACKGROUND: Several GnRH antagonist protocols are currently used during COS in the context of ART treatments; however, questions remain regarding whether these protocols are comparable in terms of efficacy and safety. OBJECTIVE AND RATIONA…

review 2022
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2022.01.011

This study compared the cost per live birth and cost-effectiveness of the originator recombinant human follicle-stimulating hormone follitropin alfa (r-hFSH-alfa) and r-hFSH-alfa biosimilars for ovarian stimulation prior to assisted reprodu…

guideline 2020
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.13222

Good evidence that oil-soluble contrast media (OSCM) enhances pregnancy rates when used to assess fallopian tube patency by hysterosalpingogram has prompted rapid clinical uptake by some fertility doctors and imaging specialists in Australi…

2007
·doi:10.1016/j.fertnstert.2007.07.679